Rapamycin decreases DNA damage accumulation and enhances cell growth of WRN-deficient human fibroblasts.
about
Metabolic and Phenotypic Differences between Mice Producing a Werner Syndrome Helicase Mutant Protein and Wrn Null MiceWerner syndrome: Clinical features, pathogenesis and potential therapeutic interventionsHow Research on Human Progeroid and Antigeroid Syndromes Can Contribute to the Longevity Dividend InitiativeJejunal Cancer with WRN Mutation Identified from Next-Generation Sequencing: A Case Study and Minireview.Prevention of carcinogen and inflammation-induced dermal cancer by oral rapamycin includes reducing genetic damageThe Werner syndrome RECQ helicase targets G4 DNA in human cells to modulate transcription.WRN Mutation Update: Mutation Spectrum, Patient Registries, and Translational ProspectsDoes the nature of residual immune function explain the differential risk of non-melanoma skin cancer development in immunosuppressed organ transplant recipients?Inhibition of mTOR enhances radiosensitivity of lung cancer cells and protects normal lung cells against radiation.Transient overexpression of Werner protein rescues starvation induced autophagy in Werner syndrome cells.Geroscience: Addressing the mismatch between its exciting research opportunities, its economic imperative and its current funding crisis.Ageing: Dietary protection for genes.Recent Advances in Understanding Werner Syndrome.An encouraging progress report on the treatment of progeria and its implications for atherogenesis.Rapamycin prevents the intervertebral disc degeneration via inhibiting differentiation and senescence of annulus fibrosus cells.Differential stem cell aging kinetics in Hutchinson-Gilford progeria syndrome and Werner syndrome.
P2860
Q27313716-0AB57014-3FA8-49EE-86BD-CB7BF07244DFQ28274227-DD28DB98-0422-4458-953B-2647D1837339Q28601451-FB2C1BDD-32E6-48FB-B565-D634BA6510F5Q33849949-8AD1FDD2-7F74-4323-A565-EFBC65D39169Q35563024-78210053-F993-4CF5-B7D8-3792420C882AQ37336151-9CB8B898-942B-4C5B-BEE1-C8C02221F0FFQ37586984-698207EB-DCAF-43F9-9805-3598A54BF98EQ38328785-F0A509E9-5481-4DC5-B76B-A6A734EA673EQ38784466-3B7E6A1D-0E0D-4AFC-A5AE-B8F1517570DFQ38953220-003B1E20-5488-453A-92BF-A53529D4FA09Q39015871-E0C145A8-3F05-49B9-846E-1B259592FB2BQ42330307-56CDC010-BFD5-4EF5-BEA4-86813DC43739Q42367242-B6629493-A4BB-4497-940B-0B957EB73759Q43140936-687B746E-0B78-4E0E-B59D-44E0091A9823Q49953085-BDE9C0C3-F291-4D3F-BC27-4E027DBEC752Q51767576-3DEC047E-773E-4BAC-A72D-D5EF85B8331D
P2860
Rapamycin decreases DNA damage accumulation and enhances cell growth of WRN-deficient human fibroblasts.
description
2014 nî lūn-bûn
@nan
2014年の論文
@ja
2014年学术文章
@wuu
2014年学术文章
@zh-cn
2014年学术文章
@zh-hans
2014年学术文章
@zh-my
2014年学术文章
@zh-sg
2014年學術文章
@yue
2014年學術文章
@zh
2014年學術文章
@zh-hant
name
Rapamycin decreases DNA damage ...... N-deficient human fibroblasts.
@en
Rapamycin decreases DNA damage ...... N-deficient human fibroblasts.
@nl
type
label
Rapamycin decreases DNA damage ...... N-deficient human fibroblasts.
@en
Rapamycin decreases DNA damage ...... N-deficient human fibroblasts.
@nl
prefLabel
Rapamycin decreases DNA damage ...... N-deficient human fibroblasts.
@en
Rapamycin decreases DNA damage ...... N-deficient human fibroblasts.
@nl
P2093
P2860
P356
P1433
P1476
Rapamycin decreases DNA damage ...... N-deficient human fibroblasts.
@en
P2093
Alexander Cypro
Bidisha Saha
George M Martin
Junko Oshima
P2860
P304
P356
10.1111/ACEL.12190
P577
2014-02-05T00:00:00Z